Mail & Guardian
Mail & Guardian
glenda graylatest news & developments
The Botswana Network on Ethics, Law and HIV/Aids says the crisis is not an isolated supply-chain issue but a ‘systemic failure’ that demands urgent government intervention

The endgame to HIV/Aids

The United States’ shutdown of HIV/Aids funding may harm global Aids programmes irreparably, jeopardising millions of lives and putting HIV prevention at risk

Finance Minister Enoch Godongwana did not announce a budget allocation to plug the gap created by the termination of USAid funding to HIV/Aids organisations (Photo by Luke Dray/Getty Images)

SA leads HIV/Aids vaccine discovery research team

USAID has pumped $45 million in grant funding to support the work of a consortium of top African scientists from eight countries

South African Medical Research Council president and chief executive Glenda Gray is stepping down to take up a full-time scientific role.

Glenda Gray steps down from South African Medical Research Council

Gray is the first female president and chief executive of the council and served as the chairperson of the research committee on Covid-19

Panic at the border: South Africa’s clever scientists discovered the Omicron Covid-19 variant last week. (Ashish Vaishnav/Sopa Images/LightRocket/Getty Images)

The anomaly of Covid-19: Living in an in-between space

The coronavirus pandemic, and ensuing variants, mean we can’t make plans without the prospect of last-minute cancellations. But there’s precious little we can do about it

Through research and partnering with communities, universities can tackle the Southern African region’s problems, such as poverty, climate change and unemployment

Academics, students urge Wits University to divest from fossil fuels

Staff and students argue it is unethical for university to profit from an industry that damages the planet and distorts science

Research also shows that violent conflict drops by up to 37% when girls and boys have equal access to education. (Photo by Matthias Balk/picture alliance via Getty Images)

As the Covid-19 third-wave hits, how many South Africans have had the virus already?

Increasing seroprevalence in South Africa could help curb the disastrous effects a third wave could have on communities. But no one is out of the woods yet

Simon Ntsiman gets his vaccination shot at the FF Robeiro Clinic at Sammy Marks Square vaccination site on May 25, 2021 in Pretoria, South Africa. This forms part of phase 1 b and phase 2 rollout of the COVID-19 vaccine.  Under phase 2, citizens aged 60 and above and other vulnerable groups are eligible to get the jab, while healthcare workers who were not vaccinated during phase 1 of the rollout may still do so under phase 1 b.  The Gauteng province increased vaccination sites in an effort to ramp up vaccination drive. (Photo by Alet Pretorius/Gallo Images via Getty Images)

Slow registration delays South Africa’s vital vaccine roll-out

This has resulted in demand exceeding supply — or vice versa — at many vaccination sites

Health Minister Dr Zweli Mkhize. (Photo Delwyn Verasamy/M&G)

How SA wants to sell the AstraZeneca vaccine for half the price and what the loss could be

Health Minister Zweli Mkhize says selling on the vaccines will stem wasteful expenditure, but people close to the discussions with AU say they will be sold on the cheap

Professors provoke breastfeeding outrage

UKZN researchers argue that government clinics should stop providing free formula milk to all HIV-infected mothers.

SA HIV vaccines on brink of human testing

Researchers from the University of Cape Town have developed two test HIV vaccines — the first wholly South African-developed products to enter the human clinical-trials phase,…

HIV vaccine trials in SA put on hold

All HIV vaccine trials in South Africa have been put on hold following the failure of the Phambili trial. Health Minister Manto Tshabalala-Msimang on Wednesday invited…

Huge disappointment as HIV vaccine trial ends

The supervisor of a major HIV vaccine trial in South Africa voiced ”huge disappointment” on Saturday after testing was halted in the wake of poor results from sister trials in…

Promising HIV vaccine trial halted in SA

A major HIV vaccine trial in South Africa was brought to a halt on Friday after interim results from a sister trial in the United States and Australia suggested it failed to…

Preliminary trial results encouraging for HIV vaccines

Parallel trials for Aids vaccines in South Africa look promising in their long road to conclusion, a press conference in Sandton heard on Friday. Indications are that vaccine…